HCV: Relapse or Reinfection? 

Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery
January 24, 2017
Bike is Designed to Mimic the Symptoms of Multiple Sclerosis
January 24, 2017
Show all

HCV: Relapse or Reinfection? 

When someone tests positive for hepatitis C a second time, is it more likely to be a relapse or a reinfection?

Today’s hepatitis C medications offer extremely high cure rates. In fact, the few cases of a previously treated patient later testing positive for hepatitis C has some patients wondering “did I relapse or could I have been reinfected?”

There are six different genotypes of the hepatitis C virus (as well as sub-genotypes). A first step to solving the mystery of relapse vs. reinfection starts with knowing which genotype was the initial infection and which genotype does a patient currently have. If the genotypes are different, it’s clear that a patient was exposed to a new strain of the virus – meaning it’s a reinfection.

In an effort to better understand this complex topic, European researchers examined a group of approximately 3,000 hepatitis C patients and tracked them closely after treatment with direct-acting anti-viral medications (sofosbuvir, either alone or in combination).

Of the patients in this study, only 12 (0.4%) “cured” patients later showed signs of hepatitis C infection. These infections were found 24 weeks after the patients were all previously deemed to have a sustained viral response (e.g., cure). Deep genetic sequencing revealed that of these 12, five of them experienced a disease relapse. The remaining 7 were discovered to have a different type of hepatitis C than the initial infection, meaning that they were reinfected. The researchers conclude that most cases of HCV recurrence are actually due to reinfection and not as a result of a relapse.

The potential for reinfection is why it is important for HCV patients to be educated about how to prevent future exposures to the hepatitis C virus (IV needle sharing, unprotected sex, etc.) after they are successfully treated.


Sarrazin C et al. Late relapse versus hepatitis C virus reinfection in patients with sustained virologic response after sofosbuvir-based therapies. Clin Infect Dis 2017 Jan 1;64:44.

Read full article: HCV: Relapse or Reinfection? | BioPlus Specialty Pharmacy

Read Full Article: HCV: Relapse or Reinfection? | BioPlus Specialty Pharmacy

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.